The Foundation for the Promotion of Health and Biomedical Research of Valencia Region (Fisabio) and the Pneumology Foundation of the Valencian Community performed a study at the Hospital General Universitario of Elche that ...
Aug 3, 2022
0
4
Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation ...
Aug 2, 2022
0
47
Everyone in the United States knows someone—often multiple someones—who have been reinfected with COVID-19.
Jul 25, 2022
0
25
The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses.
Jul 21, 2022
1
134
In case of heart and/or lung failure, an ECMO machine can be used to maintain organ function for days or even weeks. Although extracorporeal membrane oxygenation (ECMO) technology has advanced, its use can still cause fatal ...
Jul 18, 2022
0
9
Microglia, a type of central nervous system cell, is primarily responsible for neuronal death in Leigh Syndrome and the neurological symptoms related to this mitochondrial disease. This is the conclusion of a research group ...
Jul 8, 2022
0
2
A new multidisciplinary study conducted by researchers at the University of Rochester Medical Center has found that the co-development of three systems, the gut microbiome, respiratory system and immune system, is correlated ...
Jun 16, 2022
0
66
Scientists at the University of Illinois Chicago have analyzed gene expression data from more than 35,000 blood vessel cells from the lungs of mice and identified two subtypes.
Jun 14, 2022
0
92
Scientists at Johns Hopkins University and Scripps Research have characterized 30 antibodies that recognize a wide range of coronaviruses—successfully blocking not only all the SARS-CoV-2 variants that were tested but also ...
Jun 8, 2022
0
102
A large randomized, placebo-controlled clinical trial led by the National Institutes of Health shows that treating adults hospitalized with COVID-19 with infliximab or abatacept—drugs widely used to treat certain autoimmune ...
Jun 3, 2022
0
51
